Abstract
Chronic migraine (CM) is a highly disabling neurological disorder characterized by recurrent headache accompanied by a variety of sensory and/or emotional symptoms. However, the mechanisms of migraine onset and its chronicity have not been elucidated. The present study was designed to search for brain regions and neurons that were abnormally activated by CM and might be related to its pathogenesis and different concomitant symptoms. CM models were established here by repeated intraperitoneal injection of nitroglycerin (NTG) every other day for 9 days to early growth response gene 1 (Egr1)-enhanced green fluorescent protein (EGFP) transgenic mice, which allowed monitoring of neuronal activities in the whole brain. CM-related behaviors were recorded through head grooming test and light aversion assay. Elevation of Egr1 expression signals was detected in trigeminal nucleus caudalis (TNC), primary somatosensory cortex (SSp), lateral amygdala nucleus (LA), primary visual area (VISp), and temporal association areas (TEa) 2 h after the last injection of NTG by immunofluorescence and digital slice scanning technology. Meanwhile, no change of Egr1 expression was found in auditory areas (AUD), CA1, ectorhinal area (ECT), piriform (PIR), and anterior cingulate area (ACC). Furthermore, with the strongest support by evidence-based medicine among the current limited oral treatments of CM, topiramate was administrated every day for 11 days from 2 days before the first NTG injection. The results showed that topiramate partially improved the photophobia behavior of CM models in the short-term with gradually weakened efficacy as the course of the disease prolonged. Meanwhile, NTG-induced increase in Egr1 expression was completely reversed in TNC, SSp, and VISp and partially reduced in LA and TEa by topiramate at the same time point mentioned above. In conclusion, the current results suggested that the abnormal hyperactivities in TNC, SSp and VISp were associated with the pathogenesis of CM.
Highlights
MATERIALS AND METHODSMigraine is considered one of the most common types of primary headache disorders
Chronic injection of NTG decreased the time in light chamber on days 3, 5, 7, and 9 as compared with vehicle control group and the change existed 2 days after the last NTG injection (Figure 1C and Supplementary Table 3)
It is believed that migraine is a primary headache caused by the combined action of cortical spreading depression (CSD) and trigeminal neurovascular dysfunction (Brennan and Pietrobon, 2018)
Summary
Migraine is considered one of the most common types of primary headache disorders. With the development of imaging technology in recent years, there has been an increasing number of related studies on CM. Summary of clinical imaging researches demonstrates that the functional and structural changes of the brainstem, hypothalamus, thalamus, basal ganglia, and cortex are related to the occurrence of pain (Chen et al, 2020). There were differences in the results of the same brain area in different studies (Coppola et al, 2017; Neeb et al, 2017; Planchuelo-Gomez et al, 2020), which may due to the diversity in patients’ background or image processing methods
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
